ETOLOCE
Live / Registered — Registered (as of 07 Jan 2025)
What this means for you
Registered since 07 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98240030
- Registration number
- 7638977
- Mark type
- Stylized text
- Filed
- 25 Oct 2023
- Published for opposition
- 17 Sept 2024
- Registered
- 07 Jan 2025
- Attorney of record
- Stephen R. Barrese
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for the treatment of immune system related diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of ankylosing spondylitis; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for the treatment of enthesitis-related arthritis
Owner
- Samsung Bioepis Co., Ltd., Yeonsu-gu, Incheon, KR
- Samsung Bioepis Co., Ltd., Yeonsu-gu, Incheon, KR
- Samsung Bioepis Co., Ltd., Yeonsu-gu, Incheon, KR
Prosecution history
- 07 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 17 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Sept 2024 — PUBLISHED FOR OPPOSITION
- 28 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Jun 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Jun 2024 — NON-FINAL ACTION E-MAILED
- 16 Jun 2024 — NON-FINAL ACTION WRITTEN
- 07 Jun 2024 — ASSIGNED TO EXAMINER
- 31 Oct 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Oct 2023 — NEW APPLICATION ENTERED